SCHEMBL686846

SCHEMBL686846

Cc1cn(Cc2ccccc2Cl)c(=O)c(NC(=O)NC(CC(=O)O)c2ccc3ccccc3c2)c1O

nearest known ligand 0.41

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PTGER3 P43115 11/20 0.41
CNR2 P34972 1/20 0.39
SLC22A12 Q96S37 1/20 0.39
PYGL P06737 1/20 0.38
UTS2R Q9UKP6 1/20 0.37
CYP26A1 O43174 1/20 0.37
CTSA P10619 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ITGB1 P05556 2/20 0.35
ITGA4 P13612 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL686938 0.93 PTGER3 (0.47) PTGER3CNR2SLC22A12CYP26A1CTSA
SCHEMBL688170 0.92 PTGER3 (0.41) PTGER3CNR2SLC22A12CYP26A1ALDH1A1
SCHEMBL688284 0.92 PTGER3 (0.43) PTGER3CNR2SLC22A12CYP26A1CTSA
SCHEMBL688053 0.91 PTGER3 (0.43) PTGER3CNR2SLC22A12CTSAALDH1A1
SCHEMBL688442 0.90 PTGER3 (0.42) PTGER3CNR2SLC22A12PYGLCYP26A1
SCHEMBL29371834 0.90 PTGER3 (0.44) PTGER3CNR2SLC22A12CTSA
SCHEMBL686896 0.90 PTGER3 (0.44) PTGER3CNR2SLC22A12CTSA
SCHEMBL687687 0.89 PTGER3 (0.38) PTGER3CNR2SLC22A12CYP26A1ITGB1
SCHEMBL688079 0.89 PTGER3 (0.38) PTGER3CNR2SLC22A12CYP26A1CTSA
SCHEMBL687923 0.89 PTGER3 (0.41) PTGER3CNR2SLC22A12UTS2RCTSA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203766-B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC (US) 2012-02-29 EP disclosed
EP-1203766-A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors TEXAS BIOTECHNOLOGY CORPORATION (US) 2002-05-08 EP disclosed